LGD 4033 or Ligandrol came into the spotlight in 2007 thanks, to Ligand Pharmaceuticals introducing it as a androgen receptor modulator (SARM). Its known for targeting muscle and bone androgen receptors while showing results in boosting lean muscle mass in participants during initial trials, without significant androgenic side effects.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about LGD4033 by Dragon Pharma, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.